Magen et al. characterized the action of specific subsets of mregDCs and CD4+ T cells in potentiating the maturation and stimulation of CD8+ T cells in HCC patients who respond to PD-1 treatment [137]. This evidence concerns the gene CD4 and hepatocellular carcinoma.